Published in Cardiovascular Business Week, August 22nd, 2006
"Our domestic product sales increased by more than three-fold year-over-year and by 31% on a sequential quarter basis," said Endologix president and chief executive officer Paul McCormick. "We believe our sales growth reflects positively on the steps we are taking to accelerate our domestic launch, including the hiring of sales representatives with prior AAA experience, and indicates an increasing market...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.